InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: Rdunn88 post# 338986

Thursday, 01/07/2021 12:18:22 PM

Thursday, January 07, 2021 12:18:22 PM

Post# of 403568
"when the company states "it will visit the trial sites" it means the CRO it hires (contracts as its representative) will visit the site. NOT LEO OR JANE!"

I can't believe you thought they actually went to each trial site. Imagine the amount of time and money that would cost. I think Leo's time is better spent getting the manufacturing of Brilacidin ready for the millions of sick people with covid & flu.

Whenever it starts/finishes it will be good for long shareholders. I am willing to wait and I think you are going to have to wait.

Go Leo & IPIX!

Also, After Leo signs contracts for additional sites I'm assuming he'll have to visit them also? My late Feb trial start may go up in flames... March, here we come... God, one would believe he was doing a large trial? LOL


The Company will now complete site initiation visits and contracts to add additional clinical sites to the study.


http://www.ipharminc.com/press-release/2020/12/21/fda-grants-ind-approval-for-phase-2-clinical-trial-of-innovation-pharmaceuticals-brilacidin-for-treating-covid-19


FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19


Brilacidin in a human lung cell line infected by SARS-CoV-2, achieved a high Selectivity Index rating of 426.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News